Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FEFACRIGOU: Immediate vs Delayed Febuxostat in Gout
NCT05109936Phase 3Recruiting
- Sponsor
- Rouen University Hospital
- Start
- Aug 2023
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of febuxostat in gout, sponsored by Rouen University Hospital. Started Aug 2023; status: recruiting.
02
Drugs
febuxostat
03
Conditions
gout
Beyond the preview
Go deeper on NCT05109936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05109936.